CHG-2022-0299
New Dosage Strength for Atezolimumab-R. Manufacturing Process Change for Atezolimumab-R — minor update. Impacts 2 markets and 4 variations.
Change Number
CHG-2022-0299
Type
New Dosage Strength
Product
Status
Approved
Owner
Tomoko Ikeda
Initiated
2022-12-28
Description
Manufacturing Process Change for Atezolimumab-R — minor update
Impacted Markets (2)
EU — European UnionSG — Singapore
Impacted Modules
3.2.P.33.2.S5.3.5
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|